Please click on the relevant link for the information you require
All content is applicable to NHS South West London and SWL Providers (including Acute Trusts, Mental Health Trust and Community Services providers).
Valproate Shared Care (New)
The Valproate shared care guidance is for women of child bearing potential who do not meet all the criteria outlined in the Pregnancy Prevention programme. It is supported by the Valproate Safer Use Policy.
Dizziness: Treatment and Referral Pathways (for adults) in Primary Care (New)
This guidance is aimed at primary care clinicians. It outlines the primary care treatment and referral pathways for the common causes of dizziness in adults (18 years of age and above) in NHS South West London. It is also available as a visual summary flow chart. In addition, the dizziness training webinar delivered across SWL is a useful resource.
Malnutrition and Oral Nutritional Supplements prescribing guidelines (Updated October 2025)
The Malnutrition and Oral Nutritional Supplements prescribing guidelines have been updated, including Food-Based resources.
Asthma Guideline -management of adults and children (Updated October 2025)
The SWL Asthma Guidelines have been updated.
Diabetes Blood Glucose and ketones Meters, Testing Strips and Lancets position statement (Updated October 2025)
The SWL position statement on blood glucose and ketones meters, testing strips and lancets has been updated.
Guidance for Non-Medical Prescribers (NMPs) and employing organisations in all settings across SWL ICB (New June 2025)
The guidance is designed to provide good practice principles for NMPs and their employing organisations working within primary care to enable them to promote safe and effective prescribing.
Rhinitis management: London regional guideline and pathway (New April 2025)
This is a pan London guideline for the diagnosis and treatment of rhinitis.
Headache: Referral and Management pathways for adults (New April 2025)
This guideline is aimed at primary care clinicians in NHS SWL. It outlines the headache referral and management pathway for adults (18 years or older) and signposts to national and local guidance where appropriate.
Migraine (Acute)
This guideline is intended for use by clinicians in primary care for the acute treatment of migraine in adults (age 18 years and above)
Melatonin prescribing guidance (New March 2025)
The melatonin prescribing guidance for children and young adults replaces the ‘melatonin – sleep disorders in children and adolescents’ shared care agreement. However, children and adolescents who have been treated in accordance with the previous shared care i.e. melatonin modified release tablets (Circadin), will continue with their treatment. At their next review with the specialist, the treatment will be reviewed and changed, where clinically appropriate to an approved licensed formulation in line with SWL formulary
